MedTrace Logo

Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

NCT06215287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-05-17

No results posted yet for this study

Summary

The objective of this survey is to assess the knowledge of HCPs in relation to the recommended posology and biological monitoring for Exjade, based on the current locally valid Exjade educational materials (including the physician's reference checklist)

Conditions

  • Chronic Iron Overload

Interventions

OTHER

Physician survey

Survey to assess physicians' knowledge of Exjade posology and biological monitoring recommendations as described in the Educational Materials

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2024-02-15
Completion
2024-02-15

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06215287 on ClinicalTrials.gov